CDC-RFA-CK22-2204: US Public Health Pathogens Genomics Centers of Excellence
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control - NCEZID notices from 2022.
Centers for Disease Control - NCEZID offered grants to state and local governments and tribes. It expected to make about 6 awards worth $185 million in total. Applications closed on May 17, 2022.
From the official notice on Grants.gov, last changed April 14, 2022. Checked November 7, 2026.
- Total funding$185 million
- Expected awards6
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 18, 2022 |
|---|---|
| Deadline | May 17, 2022 |
| Archived by Grants.gov | June 16, 2022 |
Who can apply
This opportunity was open to state and local governments and tribes.
- State governments
- County governments
- City or township governments
- Native American tribal governments (Federally recognized)
To be deemed responsive, applications must include an Academic Letter of Support from at least one academic partner organization. If an applicant fails to submit at least one letter of support from an academic partner organization, the application will be deemed non-responsive and will receive no further review. Applicants must clearly state in the Project Abstract Summary if they are applying to only the Mandatory Components (Core, Response Implementation), or if they are applying to both the Mandatory Components (Core, Response Implementation) and Optional Component (Lead PGCoE for Education). When including this information in the Project Abstract Summary, please indicate one of the following: a) “This application is only for the Mandatory Components (Core, Response Implementation)” or b) “This application is for the Mandatory Components (Core, Response Implementation) and also includes the Optional Component (Lead PGCoE for Education).” If an applicant fails to clearly state which components are being applied for in the Project Abstract, the application will be deemed non-responsive and will receive no further review. *See Attachment A titled Additional Information on Eligibility (Continued)
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2022 funds for a cooperative agreement program to establish The US Pathogen Genomics Centers of Excellence (PGCoE) network. The underlying objective of the PGCoE network is, through partnerships between academic and public-health organizations, to foster innovation in pathogen genomics and molecular epidemiology in order to improve the control of and response to microbial threats of public-health importance. This NOFO will implement a three-pronged strategy of 1) accelerated translation of relevant pathogen genomic technologies and innovations into the US public health system, particularly in public health agencies at the local, state, tribal, territorial and national level; 2) training of the public health workforce in microbial genomics and genomic epidemiology; and 3) rapid and scalable use of pathogen genomics in responding to public health emergencies from infectious diseases in order to improve detection, characterization, and prevention of infectious disease threats.
Who has won Prevention of Disease, Disability, and Death by Infectious Diseases grants before
From fiscal 2021 to 2025, Prevention of Disease, Disability, and Death by Infectious Diseases (93.084) awarded $241 million across 128 grant awards, an average of $1.9 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Puerto Rico Science, Technology, and Research Trust | Puerto Rico | 4 | $14.5 million |
| Massachusetts Department of Public Health | Massachusetts | 1 | $11.6 million |
| Emory University | Georgia | 3 | $11.5 million |
| Uganda Virus Research Institute | 1 | $8.7 million | |
| Ponce Medical School Foundation Inc | Puerto Rico | 2 | $8.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-CK22-2204 still open?
No. It closed on May 17, 2022. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for US Public Health Pathogens Genomics Centers of Excellence?
Centers for Disease Control - NCEZID accepted applications from state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for US Public Health Pathogens Genomics Centers of Excellence?
Closed May 17, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $185 million in total across about 6 awards.
Who has won Prevention of Disease, Disability, and Death by Infectious Diseases grants before?
The largest recipients over five fiscal years were Puerto Rico Science, Technology, and Research Trust, Massachusetts Department of Public Health, Emory University. The program made 128 awards worth $241 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)